Inactive
Notice ID:36E79723R0038
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0038 for an unrestrictive procurement for Adalimumab Pen/Syringe Kits, for the Departme...
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79723R0038 for an unrestrictive procurement for Adalimumab Pen/Syringe Kits, for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA s respective Pharmaceutical Prime Vendor Programs. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have an NDC number that is unique to the offeror. Solicitation # 36E79723R0038 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about October 12, 2023, with a tentative closing date of October 26, 2023. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at sam.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Chris Carthron. Questions can be e-mailed to: Christopher.Carthron@va.gov. The estimated annual requirements are as follows: Item Description Size Estimated Annual Requirements (Kits) Group I ADALIMUMAB 40MG/0.4ML INJ,PEN,KIT 2 120,089 ADALIMUMAB 40MG/0.4ML INJ,SYRINGE,KIT 2 9,715 Group II 1 ADALIMUMAB 40MG/0.8ML INJ,PEN,KIT 2 149,641 2 ADALIMUMAB 40MG/0.8ML INJ,SYRINGE,KIT 2 23,595 *Group I and Group II do not have to be awarded to the same vendor.
